Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Iran's Health Ministry Qualifies 2nd Nano Drug for Marketing

Abstract:
Iran is due to present a second nano drug to domestic markets after the product received the approval of the Iranian Health Ministry's Nanotechnology Committee.

Iran's Health Ministry Qualifies 2nd Nano Drug for Marketing

Tehran, Iran | Posted on January 2nd, 2013

The medicine, containing nanographite, has been produced under the title Carboncelium Complex by one of the Iranian companies, and it has applications as topical ointment in burn wounds.

After passing the preliminary production stages and acquiring basic approvals from Food and Medicine Organization of the Health Ministry, the medicine was finally evaluated in Nanotechnology Committee of Food and Medicine Organization after the approval of clinical studies. Taking into consideration the documents presented about the use of nanotechnology in the production of the medicine and its significant effect in clinical studies, the medicine was allowed to be used by the public according to the approval of the Legal Commission of Medicine Department of the Health Ministry.

The medicine will be soon presented to the drug stores and hospitals across the country in order to be consumed.

Rezayat, the head of the Nanotechnology Commission of Food and Medicine Organization, confirmed that the medicine has succeeded in obtaining the approval of the commission.

According to Rezayat, this valuable research is the result of the cooperation and synergy between Food and Medicine Organization and Iran Nanotechnology Initiative Council.

According to him, files are open in this Committee for about 100 products, among which 50 are currently completing the documents required for obtaining the permission. Half of the abovementioned products are related to devices and equipment, 20 are classified in cosmetics and hygienic group, and nine are related to medicine group.

"The permission for the entrance of 13 products to the market has so far been issued, and the specialists of the Committee periodically visit the producing companies," Rezayat said.

####

For more information, please click here

Copyright © Fars News Agency

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Govt.-Legislation/Regulation/Funding/Policy

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Quantum obstacle course changes material from superconductor to insulator December 1st, 2016

Throwing new light on printed organic solar cells December 1st, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Research Study: MetaSOLTM Shatters Solar Panel Efficiency Forecasts with Innovative New Coating: Coating Provides 1.2 Percent Absolute Enhancement to Triple Junction Solar Cells December 2nd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project